Upcoming Medical Conferences in WhistlerSearch Criteria : Canada Whistler
Feb 24 - 28, 2019 | USD $1145 | Whistler, British Columbia
Long Non-Coding RNAs: From Molecular Mechanism to Functional Genetics (X2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 24 - 28, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada. Course Description : Although emerging evidence points to the critical importance of the long noncoding transcriptome in human physiology and pathology, the clinical potential of long noncoding RNAs (lncRNAs) as therapeutic and prognostic targets remain largely unexplored. The increasing availability of high-throughput technologies and newly developed computational methodologies is rapidly making it possible to address this gap in our knowledge. However, optimal use of these new capabilities and recognition of their power in transforming the field of lncRNA research requires the formation of new collaborative and training efforts. This conference specifically aims to: • Communicate the latest available technologies and developing methodologies for lncRNA functional genetics to the lncRNA community. • Promote collaborations and new research directions that will bridge the already thriving lncRNA mechanistic and basic research to the clinical need for novel, effective diagnostic, prognostic and therapeutic targets. • Contribute to attracting the attention of biotech and pharmaceutical industry and clinically-oriented funding agencies to the lncRNA field. • Integrate lncRNA research into other biological fields through the joint pairing with the conference on “RNA-Protein Interactions. Session Topics: • Functional RNA Elements in Mammalian Genomes (Joint) • lncRNAs, Transposons and Evolution of the Genome • Coding and Noncoding RNAs on Chromatin (Joint) • Regulation of Differentiation and Development by lncRNAs • lncRNAs in Disease: Tools for Discovery • Novel Insights into Functional Mechanism of lncRNAs • lncRNAs: Diversity in Form and Function • RNA and RBP in Disease (Joint) plus two workshops Additional details will be posted as soon as they are available.
Feb 24 - 28, 2019 | USD $1145 | Whistler, British Columbia
RNA-Protein Interactions (X1) is organized by Tufts University School of Dental Medicine and will be held from Feb 24 - 28, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada. Course Description : Recent evidence suggests that the human genome encodes ~1500 RNA binding proteins (RBPs), and this number may further increase by identifying additional RBPs that do not contain canonical RNA binding motifs. These proteins control gene expression at transcriptional and post-transcriptional levels in development and disease. As mutations in many RBPs have been linked to human diseases, various RBPs and their regulated events may be potential drug targets. This conference will address some long-standing problems as well as emerging paradigms in this field. In particular, it will bring together leaders in RNA research to: 1) Brainstorm around novel concepts; 2) Sare new technology developments; and 3) Explore new disease mechanisms. The conference will be highly mechanismoriented, rather than centering on a specific biological process or disease theme, which will bring together scientists across multiple fields. Since individual regulatory RNAs must enlist specific RBPs to execute their biological functions, coupling the conference with another on “Long Noncoding RNAs: From Molecular Mechanism to Functional Genetics” will thus present a cohesive theme focused on RNA biology and medicine. Plenary Session Topics: • Functional RNA Elements in Mammalian Genomes (Joint) • RNP in Phase Transition • Coding and Noncoding RNAs on Chromatin (Joint) • Dissecting RNP Functions in vivo • RNA Transport and Localization • Structure and Function of RBPs • RNP Machines and Regulation • RNA and RBP in Disease (Joint) plus two workshops Additional details will be posted as soon as they are available.
Feb 28 - Mar 03, 2019 | CME 18.25 | USD $995 | Whistler, British Columbia
9th Annual Whistler Anesthesiology Summit (WAS) is organized by University of British Columbia Continuing Professional Development (UBC CPD) and will be held from Feb 28 - Mar 03, 2019 at The Westin Resort & Spa, Whistler, Vancouver, British Columbia, Canada. The target audience for this medical event is Anesthesiologists, Anesthetists, Residents, Students, AAs. Conference Description: The mission of the Whistler Anesthesiology Summit is to deliver the highest standard in educational updates, covering all aspects of anesthesia care. Using various educational formats, we encourage participant interaction with the national and international leaders in anesthesia in order to promote excellence in anesthesia care, all in one of the most beautiful settings in the world. Accreditation: 18.25 MOC Section 1 5.0 MOC Section 3 Additional details will be posted as soon as they are available.
Mar 03 - 07, 2019 | USD $1145 | Whistler, British Columbia
Diabetes: Innovations, Outcomes and Personalized Therapies (X3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 03 - 07, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada. Course Description : Diabetes remains a public health challenge of epidemic proportions. Modern treatment algorithms are evolving to recommend higher focus on personalized approaches to diabetes care. However, as diabetes remains a disease characterized by excess elevation of a plasma biomarker, glucose, further refinement of our understanding of the disease and its comorbidities is required to provide optimal guidance for precision medicine. Advancement of research technologies and the ability to handle large data sets have enabled systems biology approaches to unravel different etiologies and pathophysiological consequences of diabetes. Future diabetes discovery efforts will focus on pairing knowledge about genetic risk and environmental triggers of diabetes associated pathologies. Using deep phenome characterization and molecular network analyses diabetes researchers will be able to launch modern translational approaches to diabetes care innovation. The objectives of the conference are to provide directional guidance for future pressure points of diabetes care and put emphasis on specific diabetes complications representing particular unmet needs. Further, forefront discoveries of genetic risk determinants and their molecular mechanisms will be presented together with lively debates about the translatability of such insights to novel curative therapies. Additional details will be posted as soon as they are available.
Mar 03 - 07, 2019 | USD $1145 | Whistler, British Columbia
Unraveling the Secrets of Kidney Disease (X4) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 03 - 07, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada. Course Description : Close to 1 in 11 people in the world suffers from kidney disease. The incidence of kidney disease is increasing especially in the developing world. This issue was recently reviewed and emphasized in a Lancet article (Global Health Atlas). Acute and chronic kidney disease is associated with a highly significant increase in cardiovascular death. Chronic kidney disease (CKD) represents a leading cause of death in the United States. There is no cure for this disease, with current treatment strategies relying on blood pressure control through blockade of the renin-angiotensin system. Such approaches only delay the development of end-stage kidney disease and can be associated with serious side effects. Recent identification of several novel mechanisms contributing to CKD development - including vascular changes, loss of podocytes and renal epithelial cells, matrix deposition, inflammation and metabolic dysregulation - has revealed new potential therapeutic approaches for CKD. This meeting will review clinical and observational studies in the kidney disease area, highlight recent advances in basic biology of kidney and kidney disease, assesses emerging strategies and agents for CKD treatment, and discuss major obstacles in drug development. This meeting will also encourage collaborations among clinicians and researchers from academic institutes and pharmaceutical laboratories and accelerate innovation in this field. There has not been a meeting in the area in kidney disease that would bring together clinicians, basic scientists and industry and foster collaboration. Small focus meetings have been organized by the International Society of Nephrology, but these meetings are limited to a single special topic. Furthermore more than half of kidney disease is caused by diabetes, this meeting will have the opportunity to understand diabetes and its complications development. Additional details will be posted as soon as they are available.
Mar 10 - 14, 2019 | USD $1145 | Whistler, British Columbia
Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit (C2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 10 - 14, 2019 at Whistler Conference Centre, Whistler, British Columbia, Canada. Course Description : Cancer immunotherapy is now an established field that has led to remarkable clinical benefit for a subset of patients. However, a deeper understanding of the mechanisms of response and resistance to current immunotherapy strategies is needed to help develop new treatments that will improve the number of patients who will benefit. This meeting will explore mechanisms related to response and resistance, including novel methodologies to identify these mechanisms, and provide insights into new targets and combinatorial therapies that are being developed. Additional details will be posted as soon as they are available.
Mar 18 - 22, 2019 | CME 20.00 | USD $1000 | Whistler, British Columbia
Current Topics in Anesthesia is organized by Northwest Anesthesia Seminars (NWAS) and will be held from Mar 18 - 22, 2019 at The Westin Resort & Spa, Whistler, Whistler, British Columbia, Canada. This course is designed for physicians, certified registered nurse anesthetists, physician assistants, nurse practitioners, registered nurses and other medical care providers who must maintain state-of-the-art knowledge of the specialty or are impacted by it. This CME Conference has been approved for a maximum of 20 AMA PRA Category 1 Credit(s)™. Program Purpose : Presentations are designed to facilitate the physician, nurse specialist, and other providers maintaining skills of the same kind to review and update knowledge and abilities in one or more of these areas vital to the practicing professional: • Possess the scientific background for clinical practice • Maintain state-of-the-art knowledge of not only the specialty but also of all additionally related disciplines which may impact it • Maintain an up-to-the-minute armamentarium of knowledge and skills for the selection and use of complex equipment, pharmacological agents, and procedures necessary for the provision of quality patient care • Manage self and colleagues to function toward common goals in the clinical setting, the clinical and educational institutions, and the community in which the practice resides • Serve as an expert in matters involving health care delivery; serve as an informed manager of clinical and educational services provided, including the acquisition and distribution of resources necessary in meeting professional goals • Provide assistance with and support of other service providers, departments, institutions, and organizations dependent upon the professional expertise of the practitioner Objectives : At the conclusion of this activity, the participant will be able to: • Apply the pertinent physical and behavioral sciences - to include but not be limited to advanced anatomy and physiology, pathophysiology, chemistry, physics, psychology, and social sciences - as they impact and are affected by the planning, delivery, and monitoring of anesthesia and related services inherent in the anesthesia professions. • Explain the selection, dosing considerations with methods of administration, safe use, and contraindications and precautions of presented pharmacological agents through the understanding of their physico-chemical properties, pharmacokinetics and pharmacodynamics, updated uses, and more recently developed additional, related, and similar drugs. • Outline comprehensive management plans for the group of patients discussed, whether related in age, physical status, cultural background, invasive procedure, anesthetic or analgesic requirements, clinical setting, adverse reactions, and/or goals of care. • Apply the principles of safety and asepsis in the performance of anesthetic procedures and administrations, equipment use, and other applications encountered during the provision of anesthesia and analgesia whether in the surgical unit, the labor and delivery suite, the pain management clinic, or other more remote location of anesthetizing services. • Incorporate the appropriate recommendations and/or requirements of pertinent external organizations, institutions, and professional groups - recognized as serving as the authority for and/or holding the responsibility to compile and approve such tenets - in the provision of anesthesia and related services, whether medical, legal, philosophical, ethical, or health care management standards. • Apply the new techniques in the clinical setting of the participant. Additional details will be posted as soon as they are available.
Mar 24 - 28, 2019 | USD $1145 | Whistler, British Columbia
Functional Cures and the Eradication of HIV (X8) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 24 - 28, 2019 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. Course Description : Human Immunodeficiency Virus type 1 (HIV) causes a persistent infection and results in acquired immunodeficiency syndrome (AIDS). AIDS has remained a global pandemic for over 40 years as HIV integrates into the genome of infected individuals and remain latent for years. While over the last decade much emphasis has been centered on pathogenesis and vaccine development, an emerging paradigm is taking place whereby targeted therapeutics are being developed to both control virus expression as well as possibly target viral infected cells for eradication. This meeting will for the first time bring together an interdisciplinary group of basic and applied scientists working on various aspects of HIV treatment and eradication strategies in an effort to translate our current understanding of HIV biology into a meaningful therapeutic and/or eradication of HIV from infected individuals. To accomplish this goal the meeting will aim to; • introduce the state of the art in vaccine and neutralizing antibody strategies used to compact HIV, • focus on transcriptional control and modulation of viral latency, and • highlight synthetic biological approaches and genetic therapies currently being developed and clinically validated to combat HIV infection. The goal of this meeting is to bring together an amalgamation of basic and applied scientists working on functional cures and eradication of HIV in an effort to not only better understand HIV treatment strategies but also the emerging technologies and approaches that will lead to the eventual eradication of HIV infection from infected individuals. Additional details will be posted as soon as they are available.
Mar 24 - 28, 2019 | USD $1145 | Whistler, British Columbia
HIV Vaccines (X7) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 24 - 28, 2019 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. Course Description : Despite dramatic progress in prevention and treatment of HIV, the pandemic continues: 2 million people are newly infected each year. Thus, the need for a preventive vaccine for HIV is as urgent as ever. Intensive research in basic immunology and virology as well as empirical clinical trial data continues to yield insights that inform vaccine efforts. The 2019 HIV Vaccines meeting will present the latest results from human clinical studies of candidate vaccines as well as the use of monoclonal antibodies for prevention; novel HIV neutralizing antibodies and their developmental pathways; T cell functions in killing and B cell help; structural insights and immunogen design; and the intersection of research for HIV eradication/cure with research on HIV vaccines, including interventions after very early antiretroviral therapy. We will also include a session on the process of bringing candidate vaccines to clinical trial, told from the diverse perspectives of laboratory investigators, industrial production, funders, and clinical researchers on the front lines. Additional details will be posted as soon as they are available.
Jun 21 - 22, 2019 | USD $300 | Whistler, British Columbia
8th Canadian Summer Oncology Update is organized by Island Events and will be held from Jun 21 - 22, 2019 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. The target audience for this medical event is oncologists, GPOs, residents, nurses, nurse practitioners and pharmacists. Additional details will be posted as soon as they are available.